GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Honz Pharmaceutical Co Ltd (SZSE:300086) » Definitions » 10-Year ROIIC %

Honz Pharmaceutical Co (SZSE:300086) 10-Year ROIIC % : 1.23% (As of Dec. 2023)


View and export this data going back to 2010. Start your Free Trial

What is Honz Pharmaceutical Co 10-Year ROIIC %?

10-Year Return on Invested Incremental Capital (10-Year ROIIC %) measures the change in earnings as a percentage of change in investment over 10-year. Honz Pharmaceutical Co's 10-Year ROIIC % for the quarter that ended in Dec. 2023 was 1.23%. High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

The industry rank for Honz Pharmaceutical Co's 10-Year ROIIC % or its related term are showing as below:

SZSE:300086's 10-Year ROIIC % is ranked worse than
58.31% of 921 companies
in the Drug Manufacturers industry
Industry Median: 3.8 vs SZSE:300086: 1.23

Honz Pharmaceutical Co 10-Year ROIIC % Historical Data

The historical data trend for Honz Pharmaceutical Co's 10-Year ROIIC % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Honz Pharmaceutical Co 10-Year ROIIC % Chart

Honz Pharmaceutical Co Annual Data
Trend Dec14 Dec15 Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
10-Year ROIIC %
Get a 7-Day Free Trial Premium Member Only Premium Member Only -3.61 -3.14 9.58 -7.75 1.23

Honz Pharmaceutical Co Quarterly Data
Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24
10-Year ROIIC % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 1.23 - - -

Competitive Comparison of Honz Pharmaceutical Co's 10-Year ROIIC %

For the Drug Manufacturers - Specialty & Generic subindustry, Honz Pharmaceutical Co's 10-Year ROIIC %, along with its competitors' market caps and 10-Year ROIIC % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Honz Pharmaceutical Co's 10-Year ROIIC % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Honz Pharmaceutical Co's 10-Year ROIIC % distribution charts can be found below:

* The bar in red indicates where Honz Pharmaceutical Co's 10-Year ROIIC % falls into.


;
;

Honz Pharmaceutical Co 10-Year ROIIC % Calculation

Honz Pharmaceutical Co's 10-Year ROIIC % for the quarter that ended in Dec. 2023 is calculated as:

10-Year ROIIC %=10-Year Incremental Net Operating Profit After Taxes (NOPAT)**/10-Year Incremental Invested Capital**
=( 14.661927 (Dec. 2023) - 2.0958108 (Dec. 2013) )/( 1829.48 (Dec. 2023) - 803.894 (Dec. 2013) )
=12.5661162/1025.586
=1.23%***

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

** Annual data of NOPAT and Invested Capital was used to calculate 10-Year ROIIC %.
*** Please be aware that the ROIIC (Return on Invested Capital) calculations are based on company-level data using the primary share class. The calculated data provided is for demonstration purposes and may slightly differ from the results displayed in the title due to potential variations caused by currency exchange rate differences throughout the year.


Honz Pharmaceutical Co  (SZSE:300086) 10-Year ROIIC % Explanation

Return on Incremental Invested Capital (ROIIC) is an extension of Return on Investment Capital (ROIC). ROIC % tells investors how efficiently that profitability is earned per dollar of company capital. ROIIC narrows the focus even further and shows how profitable each additional unit of capital investment could be. ROIIC % is a more powerful metric than ROIC because it measures how much money the company can generate going forward on future capital investments.

High ROIIC is generally an indication that your business is capital efficient or has a higher operating leverage.

Be Aware

It's important to keep in mind that when tracking ROIIC, the metric is better suited to forecasting the trend of future returns rather than measuring current return on investment.


Honz Pharmaceutical Co 10-Year ROIIC % Related Terms

Thank you for viewing the detailed overview of Honz Pharmaceutical Co's 10-Year ROIIC % provided by GuruFocus.com. Please click on the following links to see related term pages.


Honz Pharmaceutical Co Business Description

Traded in Other Exchanges
N/A
Address
No. 69 Xianlie Zhonglu, 2601 26/F Dongshan Plaza, GuangDong,Province, Guangzhou, CHN, 510095
Honz Pharmaceutical Co Ltd is engaged in providing medicines for children. The company's practice in this sector mainly involves the research and development, manufacturing and sales of pediatric medicines. It has automated and intelligent manufacturing bases in Hainan, Beijing, Hebei, Liaoning, and Guangdong.
Executives
Wang Chun Ying Supervisors
Rui Shou Hong Director
Hong Jiang You Directors, executives
Hong Zhi Hui Director
He Zi Qun Supervisors
Hong Li Ping Directors, executives
Hong Jiang Tao Director
Liu Hui Liang Executives
Hu Fei Hong Director
Li Ping Independent director
Fu Lin Jun Director

Honz Pharmaceutical Co Headlines

No Headlines